Da. Hess et al., Cytotoxicity of sulfonamide reactive metabolites: apoptosis and selective toxicity of CD8(+) cells by the hydroxylamine of sulfamethoxazole, FASEB J, 13(13), 1999, pp. 1688-1698
Treatment with sulfonamide antibiotics in HIV-infected patients is associat
ed with a high incidence (> 40%) of adverse drug events, including severe h
ypersensitivity reactions. Sulfonamide reactive metabolites have been impli
cated in the pathogenesis of these adverse reactions, Sulfamethoxazole hydr
oxylamine (SMX-HA) induces lymphocyte toxicity and suppression of prolifera
tion in vitro; the mechanism(s) of these immunomodulatory effects remain un
known, We investigated the cytotoxicity of SMX-HA via apoptosis on human pe
ripheral blood mononuclear cells and purified cell subpopulations in vitro.
CD19(+), CD4(+), and CD8(+) cells were isolated from human peripheral bloo
d by positive selection of cell surface molecules by magnetic bead separati
on. SMX-HA induced significant CD8(+) cell death (67 +/- 7%) at 100 mu M SM
X-HA, with only minimal CD4(+) cell death (8 +/- 4%). No significant subpop
ulation toxicity was shown when incubated with parent drug (SMX). Flow cyto
metry measuring phosphatidylserine externalization 24 h after treatment wit
h 100 mu M and 400 mu M SMX-HA revealed 14.1 +/- 0.7% and 25.6 +/- 4.2% ann
exin-positive cells, respectively, compared to 3.7 +/- 1.2% in control PBMC
s treated with 400 mu M SMX. Internucleosomal DNA fragmentation was observe
d in quiescent and stimulated PBMCs 48 h after incubation with SMX-HA. Our
data show that CD8(+) cells are highly susceptible to the toxic effects of
SMX-HA through enhanced cell death by apoptosis.-Hess, D. A., Sisson, M. E.
, Suria, H., Wijsman, J., Puvanesasingham, R., Madrenas, J., Rieder, M. J.
Cytotoxicity of sulfonamide reactive metabolites: apoptosis and selective t
oxicity of CD8(+) cells by the hydroxylamine of sulfamethoxazole.